Literature DB >> 19059023

The symptoms of osteoarthritis and the genesis of pain.

David J Hunter1, Jason J McDougall, Francis J Keefe.   

Abstract

This article delineates the characteristic symptoms and signs associated with OA and how they can be used to make the clinical diagnosis. The predominant symptom in most patients is pain. The remainder of the article focuses on what we know causes pain in OA and contributes to its severity. Much has been learned over recent years; however, for the budding researcher much of this puzzle remains unexplored or inadequately understood.

Entities:  

Mesh:

Year:  2009        PMID: 19059023     DOI: 10.1016/j.mcna.2008.08.008

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  24 in total

Review 1.  A current review of molecular mechanisms regarding osteoarthritis and pain.

Authors:  Andrew S Lee; Michael B Ellman; Dongyao Yan; Jeffrey S Kroin; Brian J Cole; Andre J van Wijnen; Hee-Jeong Im
Journal:  Gene       Date:  2013-07-02       Impact factor: 3.688

2.  Inhibition of early response genes prevents changes in global joint metabolomic profiles in mouse post-traumatic osteoarthritis.

Authors:  D R Haudenschild; A K Carlson; D L Zignego; J H N Yik; J K Hilmer; R K June
Journal:  Osteoarthritis Cartilage       Date:  2018-12-18       Impact factor: 6.576

3.  Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain.

Authors:  Shouan Zhu; Jianxi Zhu; Gehua Zhen; Yihe Hu; Senbo An; Yusheng Li; Qin Zheng; Zhiyong Chen; Ya Yang; Mei Wan; Richard Leroy Skolasky; Yong Cao; Tianding Wu; Bo Gao; Mi Yang; Manman Gao; Julia Kuliwaba; Shuangfei Ni; Lei Wang; Chuanlong Wu; David Findlay; Holger K Eltzschig; Hong Wei Ouyang; Janet Crane; Feng-Quan Zhou; Yun Guan; Xinzhong Dong; Xu Cao
Journal:  J Clin Invest       Date:  2019-02-04       Impact factor: 14.808

4.  Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint.

Authors:  Joseph R Ghilardi; Katie T Freeman; Juan M Jimenez-Andrade; Kathleen A Coughlin; Magdalena J Kaczmarska; Gabriela Castaneda-Corral; Aaron P Bloom; Michael A Kuskowski; Patrick W Mantyh
Journal:  Arthritis Rheum       Date:  2012-07

5.  Efficacy of zoledronic acid in treatment of teoarthritis is dependent on the disease progression stage in rat medial meniscal tear model.

Authors:  De-gang Yu; Bo Yu; Yuan-qing Mao; Xin Zhao; Xiao-qing Wang; Hui-feng Ding; Lei Cao; Guang-wang Liu; Shao-bo Nie; Shen Liu; Zhen-an Zhu
Journal:  Acta Pharmacol Sin       Date:  2012-05-21       Impact factor: 6.150

6.  Botulinum toxin therapy for osteoarticular pain: an evidence-based review.

Authors:  Jasvinder A Singh
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-04-01       Impact factor: 5.346

7.  Managing knee osteoarthritis with yoga or aerobic/strengthening exercise programs in older adults: a pilot randomized controlled trial.

Authors:  Corjena Cheung; Jean F Wyman; Ulf Bronas; Teresa McCarthy; Kyle Rudser; Michelle A Mathiason
Journal:  Rheumatol Int       Date:  2016-12-02       Impact factor: 2.631

Review 8.  The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease.

Authors:  Nicola Barrie; Nicholas Manolios
Journal:  Eur J Rheumatol       Date:  2017-09-01

9.  Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial.

Authors:  Stephen P Messier; Shannon L Mihalko; Claudine Legault; Gary D Miller; Barbara J Nicklas; Paul DeVita; Daniel P Beavers; David J Hunter; Mary F Lyles; Felix Eckstein; Jeff D Williamson; J Jeffery Carr; Ali Guermazi; Richard F Loeser
Journal:  JAMA       Date:  2013-09-25       Impact factor: 56.272

10.  Does Kinesiology Taping Improve Muscle Strength and Function in Knee Osteoarthritis? A Single-Blind, Randomized and Controlled Study.

Authors:  Halil Öğüt; Hayal Güler; Mustafa Turgut Yildizgören; Onur Velioğlu; Ayşe Dicle Turhanoğlu
Journal:  Arch Rheumatol       Date:  2018-01-18       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.